Mer­ck’s $10.8B Prometheus buy­out, GSK’s $2B Bel­lus takeover fu­el M&A buzz; CAR-T da­ta leak; Best of #AACR23; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

We’re get­ting ready to dive in­to Q1 earn­ings next week from some of the biggest phar­ma play­ers. There are al­so sev­er­al key FDA de­ci­sions on our watch list. Stay tuned for the most up-to-date cov­er­age.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER